The Centers for Medicare & Medicaid Services is accepting applications from eligible entities — including hospitals that employ clinicians, critical access hospitals and rural health clinics — to participate in the Primary Care Initiative’s professional and global direct contracting options in calendar year 2020. Both options offer capitated payment and performance-based shared savings and losses. Participants in the professional option will retain half of any savings and pay back half of any losses to Medicare under the model, while participants in the global option will retain all savings and pay back any losses. The 2020 implementation period will provide an opportunity for direct contracting entities, especially those who have not traditionally provided services to a Medicare fee-for-service population, to conduct outreach for voluntary alignment of beneficiaries to the model. CMS plans to open an application period next spring for entities interested in starting in 2021, the first of five performance years for the model. Prospective applicants who have not already submitted a non-binding letter of intent to apply must do so by Dec. 10. For more information, see the CMS factsheet.  

Headline
The Centers for Medicare & Medicaid Services has released an updated FAQ on Protecting Access to Medicare Act private payer data reporting. The deadline is…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The AHA provided a statement to the House Ways and Means Committee for a markup July 15 on various pieces of health legislation. The AHA offered…
Headline
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…